Prognosis of Children with HIV-1 Infection Starting Antiretroviral Therapy in Southern Africa: A Collaborative Analysis of Treatment Programs

Davies, Mary-Ann; May, Margaret; Bolton-Moore, Carolyn; Chimbetete, Cleophas; Eley, Brian; Garone, Daniela; Giddy, Janet; Moultrie, Harry; Ndirangu, James; Phiri, Sam; Rabie, Helena; Technau, Karl; Wood, Robin; Boulle, Andrew; Egger, Matthias; Keiser, Olivia (2014). Prognosis of Children with HIV-1 Infection Starting Antiretroviral Therapy in Southern Africa: A Collaborative Analysis of Treatment Programs. Pediatric infectious disease journal, 33(6), pp. 608-616. Lippincott Williams & Wilkins 10.1097/INF.0000000000000214

[img]
Preview
Text
Davies PediatrInfectDisJ 2013.pdf - Accepted Version
Available under License Publisher holds Copyright.

Download (845kB) | Preview
[img]
Preview
Text
Davies PediatrInfectDisJ 2014.pdf - Published Version
Available under License Publisher holds Copyright.

Download (546kB) | Preview

BACKGROUND: Prognostic models for children starting antiretroviral therapy (ART) in Africa are lacking. We developed models to estimate the probability of death during the first year receiving ART in Southern Africa. METHODS: We analyzed data from children ≤10 years old who started ART in Malawi, South Africa, Zambia or Zimbabwe from 2004-2010. Children lost to follow-up or transferred were excluded. The primary outcome was all-cause mortality in the first year of ART. We used Weibull survival models to construct two prognostic models: one with CD4%, age, WHO clinical stage, weight-for-age z-score (WAZ) and anemia and one without CD4%, because it is not routinely measured in many programs. We used multiple imputation to account for missing data. RESULTS: Among 12655 children, 877 (6.9%) died in the first year of ART. 1780 children were lost to follow-up/transferred and excluded from main analyses; 10875 children were included. With the CD4% model probability of death at 1 year ranged from 1.8% (95% CI: 1.5-2.3) in children 5-10 years with CD4% ≥10%, WHO stage I/II, WAZ ≥-2 and without severe anemia to 46.3% (95% CI: 38.2-55.2) in children <1 year with CD4% <5%, stage III/IV, WAZ< -3 and severe anemia. The corresponding range for the model without CD4% was 2.2% (95% CI: 1.8-2.7) to 33.4% (95% CI: 28.2-39.3). Agreement between predicted and observed mortality was good (C-statistics=0.753 and 0.745 for models with and without CD4% respectively). CONCLUSION: These models may be useful to counsel children/caregivers, for program planning and to assess program outcomes after allowing for differences in patient disease severity characteristics.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine

UniBE Contributor:

Egger, Matthias and Keiser, Olivia

Subjects:

600 Technology > 610 Medicine & health
300 Social sciences, sociology & anthropology > 360 Social problems & social services

ISSN:

0891-3668

Publisher:

Lippincott Williams & Wilkins

Language:

English

Submitter:

Doris Kopp Heim

Date Deposited:

21 Feb 2014 12:37

Last Modified:

31 Jul 2015 02:30

Publisher DOI:

10.1097/INF.0000000000000214

PubMed ID:

24378936

BORIS DOI:

10.7892/boris.41418

URI:

https://boris.unibe.ch/id/eprint/41418

Actions (login required)

Edit item Edit item
Provide Feedback